Interferon alfa-2b, recombinant; 10 million, 18 million, or 50 million IU per vial; pwd for inj after reconstitution/dilution; preservative-free; contains albumin.
Over the past 35 years, interferons have been explored in various formulations for the management of Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs), such as essential ...
Demonstrates Additive Anti-Cancer Effect in Bladder Cancer In-Vitro Model when Light-Activated Ruvidar(R) is Combined with InterferonToronto, Ontario--(Newsfile Corp. - March 2, 2026) - Theralase® ...
* Peg-Avonex shown safe and effective * Drug designed to reduce interferon dosing schedules * Analysts have modest expectations for product (Updates with additional analyst comment, share price) Jan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results